Latest issue of Clinical laboratory
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Bio-Rad and Element Biosciences Partner to Deliver Seamless RNA Sequencing Workflow Between Element’s AVITI™ System and Bio-Rad’s SEQuoia™ Express and SEQuoia™ Complete Stranded RNA Library Prep Kits
, /in E-News /by panglobalBio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, and Element Biosciences, Inc., developer of a new DNA sequencing platform disrupting genomics, today announced a partnership to demonstrate the capabilities of the Bio-Rad SEQuoia RNA Sequencing Library Preparation portfolio on the Element AVITI™ Benchtop Sequencer.
Bio-Rad Showcases Compatibility of SEQuoia™ RNA Library Preparation Kits with New Innovative Sequencers at AGBT 2023
, /in E-News /by panglobalBio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, has developed partnerships with leading innovative next-generation sequencing (NGS) instrument providers and announces compatibility of the SEQuoia RNA Sequencing Library Preparation portfolio on new state-of-the-art sequencers, including the Singular Genomics G4™ System.
New software enables remote 2D rack reading
, /in E-News /by panglobalDP5 is the latest version of Ziath’s market leading 2D rack decoding software. Drawing upon the latest technologies, DP5 can be run from a laptop, desktop, phone, tablet, or any other network connected device. Using high-speed, web-based, communications protocols – DP5 allows users to run a single scanner in the lab, or multiple scanners connected […]
Bio-Rad’s CFX Opus Deepwell Dx Real-Time PCR System Advances Large Reaction Volume IVD Assay Development and Diagnostic Testing
, /in E-News /by panglobalBio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of the CFX Opus Deepwell Dx Real-Time PCR System, a real-time PCR system listed with the U.S. Food and Drug Administration (FDA) for in vitro diagnostic (IVD) testing, and developed in accordance with […]
Wi-Fi enabled tube reader
, /in Product News /by panglobalThe DataPaq™ Handheld 2 tube reader from Ziath can be held and operated in one hand, leaving the other free for tube handling. Designed for easy portability, the Handheld 2 is a dedicated standalone device for rapidly reading single 2D bar-coded tubes. Its highly intuitive interface, and easy-to-read display, simplify and speed operation.
TRIMERO Diagnostics offers assays for testing Serum Amyloid A (SAA) on Beckman Coulter’s IMMAGE® Immunochemical Systems and Clinical Chemistry Analyzers.
, /in Product News /by panglobalMain features of the assays are: particle-enhanced rate-nephelometric method (kinetic-PENIA) for IMMAGE® 800 particle-enhanced turbidimetric method for clinical chemistry analyzers values traced to the Serum Amyloid A (SAA) 1st International Standard (NIBSC code: 92/680) of the WHO (World Health Organization).
DiaSys Procalcitonin FS is a fluid-stable, particle enhanced immunoturbidimetric assay, applicable on various clinical chemistry analyzers.
, /in Product News /by panglobalThe assay shows good precision at clinical cut-off level, a wide measuring range and high prozone security. Furthermore, Procalcitonin FS has excellent onboard and calibration stability and a high tolerance to endogenous interferents and common therapeutics used in sepsis management.
Tetra Pharm Technologies secures €9 million in Series A Round to expand R&D Operations
, /in E-News /by panglobalThe Scandinavian Biotech company, Tetra Pharm Technologies has secured €9M in a series A round led by a group of Danish investors. The company, with operations in Copenhagen, Denmark focuses on therapeutics targeting the endocannabinoid system to treat neuropathic pain and mental health disorders.
Watchmaker Genomics is proud to announce that its Quality Management System has achieved ISO 13485:2016 certification.
, /in E-News /by panglobalISO 13485 is an internationally recognized standard that sets out the requirements for a quality management system for the medical device industry. Our certificate has been awarded for the design, development, manufacture, contract manufacture, distribution, and support of high-performing reagents for genomic applications in medical research.
Shimadzu
, /in Advertenties /by panglobalFits perfectly into your workflow